Kissei Pharmaceutical Co., Ltd. (TYO: 4547)
Japan
· Delayed Price · Currency is JPY
3,865.00
+10.00 (0.26%)
Jan 23, 2025, 3:30 PM JST
Kissei Pharmaceutical Revenue
Kissei Pharmaceutical had revenue of 21.30B JPY in the quarter ending September 30, 2024, with 20.59% growth. This brings the company's revenue in the last twelve months to 81.07B, up 13.21% year-over-year. In the fiscal year ending March 31, 2024, Kissei Pharmaceutical had annual revenue of 75.58B with 11.98% growth.
Revenue (ttm)
81.07B
Revenue Growth
+13.21%
P/S Ratio
2.12
Revenue / Employee
45.57M
Employees
1,779
Market Cap
165.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 75.58B | 8.09B | 11.98% |
Mar 31, 2023 | 67.49B | 2.11B | 3.23% |
Mar 31, 2022 | 65.38B | -3.66B | -5.31% |
Mar 31, 2021 | 69.04B | 5.81B | 9.19% |
Mar 31, 2020 | 63.23B | -9.06B | -12.54% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Terumo | 986.67B |
Otsuka Holdings | 2,269.56B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |